| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/04/1995 | CA1335105C 1.alpha.-hydroxyvitamin d2 epimer and derivatives |
| 03/30/1995 | WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 03/29/1995 | EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists |
| 03/29/1995 | EP0569411B1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 03/29/1995 | CN1100631A Chondroprotective agents |
| 03/24/1995 | CA2132579A1 Adhesion receptor antagonists iii |
| 03/23/1995 | WO1995007934A2 Il8 inhibitors |
| 03/23/1995 | WO1995007701A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 03/23/1995 | CA2171829A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 03/22/1995 | EP0643767A1 Osteogenic peptides |
| 03/22/1995 | EP0643716A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 03/21/1995 | US5399743 Osteoporosis, hypercalcemia |
| 03/16/1995 | WO1995007108A2 Formulations for delivery of osteogenic proteins |
| 03/15/1995 | EP0643071A1 Compound for inhibiting bone resorption and accelerating osteogenesis |
| 03/15/1995 | EP0642521A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 03/15/1995 | EP0642520A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 03/15/1995 | EP0642519A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism |
| 03/15/1995 | EP0642518A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism |
| 03/15/1995 | EP0642517A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism |
| 03/15/1995 | EP0642513A1 Indolocarbazole imides and their use |
| 03/15/1995 | EP0573604B1 Methods for the treatment of osteoporosis |
| 03/14/1995 | US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces |
| 03/14/1995 | US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same |
| 03/08/1995 | EP0527922B1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
| 03/08/1995 | CN1099801A Peptides |
| 03/08/1995 | CN1099760A Cyclic adhesion inhibitors |
| 03/08/1995 | CN1099759A 哌嗪衍生物 Piperazine derivatives |
| 03/08/1995 | CN1099613A Method and medical agent for diagnosis and/or therapy of arthritis |
| 03/07/1995 | US5395831 Atherosclerosis and osteoporosis treatment |
| 03/07/1995 | US5395826 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 03/07/1995 | US5395824 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same |
| 03/02/1995 | WO1995006077A2 Polymeric matrices and their uses in pharmaceutical compositions |
| 03/01/1995 | EP0640339A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
| 03/01/1995 | EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1995 | US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism |
| 02/28/1995 | US5393763 Methods for inhibiting bone loss |
| 02/28/1995 | US5393749 Method of treating osteoporosis with 1 α25-dihydroxy-22(E)-dehydro-vitamin D3 |
| 02/28/1995 | US5393748 Methylenebisphosphonic acid derivatives |
| 02/28/1995 | US5393739 Use of bone morphogenetic protein in synergistic combination with TGF-β for bone repair |
| 02/26/1995 | CA2130617A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
| 02/22/1995 | EP0639644A1 New macrolides and their use |
| 02/22/1995 | EP0639224A1 Lectin domain variants of selectin |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | CN1098907A Dry mix formulation for bisphosphonic acids |
| 02/21/1995 | US5391776 Steroid derivatives |
| 02/21/1995 | US5391775 Process for production of diacetylrhein |
| 02/21/1995 | US5391569 Treating osteoporosis, inflammatory disorders |
| 02/17/1995 | CA2130044A1 Macrolides and the use thereof |
| 02/15/1995 | CN1098648A "Xiaofengtong" injection and its manufacturing method |
| 02/14/1995 | US5389614 Anticoagulants |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995003764A1 Skin patches and methods for providing testosterone |
| 02/08/1995 | EP0637245A1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 01/31/1995 | US5386031 Process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4H-pyrrolo[3,]pyrimidin-4-ones |
| 01/31/1995 | US5385908 Immunosuppressants, antiinflammatory agents |
| 01/31/1995 | US5385887 Protein, sugar, glycine, glutamic acid hydrochloride |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/25/1995 | EP0635270A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/25/1995 | EP0635266A1 Composition comprising an omega 9 series unsaturated fatty acid in the treatment of medical symptions caused by leucotriene B4 |
| 01/25/1995 | CN1097625A Compound for curing spur and cervical spondylopathy and its application in plaster |
| 01/24/1995 | US5384319 Aminoalkylphenyl compounds |
| 01/24/1995 | CA2038409C Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 01/23/1995 | CA2128376A1 Parathyroid hormone and raloxifene for increasing bone mass |
| 01/19/1995 | WO1995001960A1 Novel structural analogues of vitamin d |
| 01/18/1995 | EP0634173A1 24-epi-1-alpha-hydroxyvitamin D2 for treating osteoporosis |
| 01/18/1995 | CN1097421A Adhesion receptor antagonists |
| 01/18/1995 | CN1097420A Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes |
| 01/18/1995 | CN1097313A Snake spirit for rheumatism and its preparation |
| 01/11/1995 | EP0633021A1 Chondroprotective agents |
| 01/11/1995 | CN1097131A Ganling Dan (a ready-made Chinese medicine for curing hepatic disease in a form of powder or pellet) |
| 01/10/1995 | CA2126512A1 Chondroprotective agents |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1994017099A3 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/04/1995 | EP0632053A2 Cyclic adhesion inhibitors |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 12/28/1994 | EP0630248A1 Use if estriol for treating climacteric osteoporosis |
| 12/28/1994 | EP0630245A1 Protein kinase c inhibitor |
| 12/28/1994 | CN1096787A Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| 12/27/1994 | US5376647 bisphosphonic acid derivatives, and useful as a bone resorption inhibitor |
| 12/22/1994 | WO1994029336A1 New peptide derivatives |
| 12/22/1994 | WO1994029299A1 Imidazole lipoxygenase inhibitors |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028936A1 Process for the preparation of an oral solid dosage form containing diclofenac |
| 12/22/1994 | WO1994028923A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/21/1994 | EP0629409A1 Tetrapyrrole carboxylic acid derivatives for diagnosis and/or therapy of arthritis |
| 12/20/1994 | US5374772 Substituted benzoic acids, inhibitors of phospholipases A2 |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
| 12/13/1994 | US5373004 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds |
| 12/13/1994 | US5372809 Antigenic matrix metalloproteinase peptides |
| 12/08/1994 | WO1994027988A1 Optically pure salts of pyridinylmethyl sulfinyl-ih-benzimidazole compounds |
| 12/08/1994 | CA2337581A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds and intermediates in the preparation therefor |
| 12/07/1994 | EP0626969A1 CoA-IT AND PAF INHIBITORS |
| 12/06/1994 | US5371098 Use of oxazole compounds to treat osteoporosis |
| 11/30/1994 | EP0626389A1 Recombinant antibodies specific for TNF-alpha |